DrugPatentWatch Database Preview

Details for Patent: 10,213,415

« Back to Dashboard

Which drugs does patent 10,213,415 protect, and when does it expire?

Patent 10,213,415 protects VIBERZI and is included in one NDA.

This patent has eighty-two patent family members in thirty-four countries.

Summary for Patent: 10,213,415

Title:	Compounds as opioid receptor modulators
Abstract:	The present invention is directed to novel opioid receptor modulators of Formula (I). ##STR00001## The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors.
Inventor(s):	Breslin; Henry J. (Lansdale, PA), Cai; Chaozhong (North Wales, PA), He; Wei (Audubon, PA), Kavash; Robert W. (Glenside, PA)
Assignee:	Janssen Pharmaceutica NV (Beerse, BE)
Application Number:	15/616,358
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,213,415
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 10,213,415

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Allergan Holdings	VIBERZI	eluxadoline	TABLET;ORAL	206940-001	May 27, 2015		RX	Yes	No				Y		TREATMENT OF PAIN ASSOCIATED WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE)
Allergan Holdings	VIBERZI	eluxadoline	TABLET;ORAL	206940-002	May 27, 2015		RX	Yes	Yes				Y		TREATMENT OF PAIN ASSOCIATED WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE)

International Family Members for US Patent 10,213,415

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	048269
Argentina	095848
Austria	516274
Australia	2005224091
Brazil	PI0508820